Physician profile
George A Farhat
NPI 1942205067
$715.30
in general payments reported to CMS, 2019-2025
24 companies · $18.30 in 2025
The $18.30 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $65.34 · 2021: $86.90 · 2022: $161 · 2023: $225 · 2024: $52.88 · 2025: $18.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $94.07 | 2023 | Ztlido |
| Forte Bio-Pharma LLC | $57.22 | 2023 | Prolate, Nalocet |
| Lundbeck LLC | $53.33 | 2021-2025 | Vyepti |
| Vision Quest Industries INC. | $49.81 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.69 | 2022 | |
| Daiichi Sankyo INC. | $35.67 | 2019 | |
| Allergan, INC. | $34.31 | 2020 | |
| Abbvie INC. | $31.74 | 2021 | |
| Collegium Pharmaceutical, INC. | $29.80 | 2019-2020 | |
| Spinal Simplicity, LLC | $28.93 | 2024 | Ha Minuteman G3-R |
| Pfizer INC. | $28.34 | 2019-2023 | |
| Vertex Pharmaceuticals Incorporated | $23.95 | 2024 | |
| Horizon Therapeutics Plc | $23.02 | 2022 | |
| Baudax Bio INC. | $22.78 | 2021 | |
| Abbott Laboratories | $22.16 | 2023 | Eterna |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $18.85 | 2023 | Quviviq |
| Curonix LLC | $18.08 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kowa Pharmaceuticals America, INC. | $17.38 | 2022 | |
| Merck Sharp & Dohme LLC | $16.96 | 2020 | |
| Grt US Holding, INC. | $14.96 | 2019 | |
| Amgen INC. | $14.70 | 2021 | |
| Lilly USA, LLC | $14.15 | 2019 | |
| Amneal Pharmaceuticals LLC | $12.35 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Farhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.